Literature DB >> 33349502

MAGGIC, STS, and EuroSCORE II Risk Score Comparison After Aortic and Mitral Valve Surgery.

David X Zhuo1, Kenneth C Bilchick2, Kajal P Shah2, Nishaki K Mehta2, Hunter Mwansa3, Kanasa Nkanza-Kabaso4, Younghoon Kwon5, Khadijah K Breathett6, Ebony J Hilton-Buchholz7, Sula Mazimba2.   

Abstract

OBJECTIVES: To compare the Meta-Analysis Global Group in Chronic Heart Failure (MAGGIC) risk score with the established Society of Thoracic Surgeons (STS) and EuroSCORE II risk prediction models regarding mortality discrimination after aortic and mitral valve surgery.
DESIGN: Retrospective cohort study.
SETTING: Single tertiary academic medical center. PARTICIPANTS: A total of 259 patients who underwent open aortic valve replacement or open mitral valve repair/replacement from 2009-2014.
INTERVENTIONS: Retrospective chart review.
MEASUREMENTS AND MAIN RESULTS: MAGGIC, STS, and EuroSCORE II risk scores for each patient were studied using binary logistic regression and receiver operating characteristic analysis for the primary endpoint of one-year mortality and secondary endpoint of 30-day mortality. One-year mortality C-statistics were similar across risk scores (STS 0.709, 95% confidence interval [CI] 0.578-0.841; MAGGIC 0.673, 95% CI 0.547-0.799; EuroSCORE II 0.642, 95% CI 0.521-0.762; p = 0.56 between STS and MAGGIC; p = 0.20 between STS and EuroSCORE II; and p = 0.69 between MAGGIC and EuroSCORE II). Thirty-day mortality C-statistics also were similar between STS (0.797, 95% CI 0.655-0.939; p < 0.0001 v null hypothesis), MAGGIC (0.721, 95% CI 0.581-0.860; p = 0.33 v STS), and EuroSCORE II (0.688, 95% CI 0.557-0.818; p = 0.06 v STS; p = 0.68 v MAGGIC).
CONCLUSIONS: The MAGGIC risk score performs similarly to STS and EuroSCORE II risk models in mortality discrimination after aortic and mitral valve surgery, albeit in a small sample size. This finding has important implications in establishing MAGGIC as a viable prognostic model in this population subset, with fewer variables and ease of use representing key advantages over STS and EuroSCORE II.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  EuroSCORE II; MAGGIC; Meta-Analysis Global Group in Chronic Heart Failure; STS; Society of Thoracic Surgeons; aortic valve replacement; mitral valve repair/replacement; mortality; perioperative risk assessment; valvular heart surgery

Mesh:

Year:  2020        PMID: 33349502      PMCID: PMC8076089          DOI: 10.1053/j.jvca.2020.11.053

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.894


  22 in total

1.  The society of thoracic surgeons 30-day predicted risk of mortality score also predicts long-term survival.

Authors:  John D Puskas; Patrick D Kilgo; Vinod H Thourani; Omar M Lattouf; Edward Chen; J David Vega; William Cooper; Robert A Guyton; Michael Halkos
Journal:  Ann Thorac Surg       Date:  2011-10-13       Impact factor: 4.330

2.  Society of Thoracic Surgeons Risk Score and EuroSCORE-2 Appropriately Assess 30-Day Postoperative Mortality in the STICH Trial and a Contemporary Cohort of Patients With Left Ventricular Dysfunction Undergoing Surgical Revascularization.

Authors:  Nadia Bouabdallaoui; Susanna R Stevens; Torsten Doenst; Mark C Petrie; Nawwar Al-Attar; Imtiaz S Ali; Andrew P Ambrosy; Anna K Barton; Raymond Cartier; Alexander Cherniavsky; Pierre Demondion; Patrice Desvigne-Nickens; Robert R Favaloro; Sinisa Gradinac; Petra Heinisch; Anil Jain; Marek Jasinski; Jerome Jouan; Renato A K Kalil; Lorenzo Menicanti; Robert E Michler; Vivek Rao; Peter K Smith; Marian Zembala; Eric J Velazquez; Hussein R Al-Khalidi; Jean L Rouleau
Journal:  Circ Heart Fail       Date:  2018-11       Impact factor: 8.790

3.  Youden Index and optimal cut-point estimated from observations affected by a lower limit of detection.

Authors:  Marcus D Ruopp; Neil J Perkins; Brian W Whitcomb; Enrique F Schisterman
Journal:  Biom J       Date:  2008-06       Impact factor: 2.207

4.  2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Rick A Nishimura; Catherine M Otto; Robert O Bonow; Blase A Carabello; John P Erwin; Lee A Fleisher; Hani Jneid; Michael J Mack; Christopher J McLeod; Patrick T O'Gara; Vera H Rigolin; Thoralf M Sundt; Annemarie Thompson
Journal:  J Am Coll Cardiol       Date:  2017-03-15       Impact factor: 24.094

5.  Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies.

Authors:  Stuart J Pocock; Cono A Ariti; John J V McMurray; Aldo Maggioni; Lars Køber; Iain B Squire; Karl Swedberg; Joanna Dobson; Katrina K Poppe; Gillian A Whalley; Rob N Doughty
Journal:  Eur Heart J       Date:  2012-10-24       Impact factor: 29.983

6.  The MAGGIC risk score predicts mortality in patients undergoing transcatheter aortic valve replacement: sub-analysis of the OCEAN-TAVI registry.

Authors:  Hirofumi Hioki; Yusuke Watanabe; Ken Kozuma; Hideyuki Kawashima; Fukuko Nagura; Makoto Nakashima; Akihisa Kataoka; Masanori Yamamoto; Toru Naganuma; Motoharu Araki; Norio Tada; Shinichi Shirai; Futoshi Yamanaka; Akihiro Higashimori; Kazuki Mizutani; Minoru Tabata; Kensuke Takagi; Hiroshi Ueno; Kentaro Hayashida
Journal:  Heart Vessels       Date:  2019-05-29       Impact factor: 2.037

Review 7.  Valvular Heart Disease in Patients ≥80 Years of Age.

Authors:  Susheel K Kodali; Poonam Velagapudi; Rebecca T Hahn; Dawn Abbott; Martin B Leon
Journal:  J Am Coll Cardiol       Date:  2018-05-08       Impact factor: 24.094

8.  Predicting survival in heart failure: validation of the MAGGIC heart failure risk score in 51,043 patients from the Swedish heart failure registry.

Authors:  Ulrik Sartipy; Ulf Dahlström; Magnus Edner; Lars H Lund
Journal:  Eur J Heart Fail       Date:  2013-12-14       Impact factor: 15.534

9.  Performance of the EuroSCORE II and the Society of Thoracic Surgeons score in patients undergoing aortic valve replacement for aortic stenosis.

Authors:  Piotr Duchnowski; Tomasz Hryniewiecki; Mariusz Kuśmierczyk; Piotr Szymanski
Journal:  J Thorac Dis       Date:  2019-05       Impact factor: 2.895

10.  Performance of the MAGGIC heart failure risk score and its modification with the addition of discharge natriuretic peptides.

Authors:  Mitsuaki Sawano; Yasuyuki Shiraishi; Shun Kohsaka; Toshiyuki Nagai; Ayumi Goda; Atsushi Mizuno; Yasumori Sujino; Yuji Nagatomo; Takashi Kohno; Toshihisa Anzai; Keiichi Fukuda; Tsutomu Yoshikawa
Journal:  ESC Heart Fail       Date:  2018-03-09
View more
  1 in total

1.  Clinical Impact of Heart Team Decisions for Patients With Complex Valvular Heart Disease: A Large, Single-Center Experience.

Authors:  Francesco Burzotta; Francesca Graziani; Carlo Trani; Cristina Aurigemma; Piergiorgio Bruno; Antonella Lombardo; Giovanna Liuzzo; Marialisa Nesta; Gaetano Antonio Lanza; Enrico Romagnoli; Gabriella Locorotondo; Antonio Maria Leone; Natalia Pavone; Claudio Spalletta; Gemma Pelargonio; Tommaso Sanna; Nadia Aspromonte; Franco Cavaliere; Filippo Crea; Massimo Massetti
Journal:  J Am Heart Assoc       Date:  2022-05-27       Impact factor: 6.106

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.